{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:15:51Z","timestamp":1785838551410,"version":"3.56.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ratchadapisek Sompoch Endowment Fund","award":["RA63\/079"],"award-info":[{"award-number":["RA63\/079"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>Medulloblastoma (MB) is the most common childhood malignant brain tumor worldwide. Recently, molecular classification was established and started to play a role in the management of MB; however, studies involving molecular defined MB in Southeast Asia have been limited. We aimed to describe, and correlate clinical characteristics and molecular subgroups with therapeutic outcomes of Thai pediatric patients with MB.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Materials and methods<\/jats:title>\n<jats:p>Pediatric MB patients treated at King Chulalongkorn Memorial Hospital in Thailand from 2006 to 2018 were recruited. Patients were classified by clinical characteristics into standard- and high-risk groups, which determined treatment regimen. Retrospectively, available tumor tissues were classified into 3 molecular subgroups using immunohistochemistry: 1) WNT, 2) SHH, and 3) non-WNT\/non-SHH. The primary outcome was 5-year overall survival (OS). Risk factors associated with OS were analyzed using cox regression analysis.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Fifty-three Thai pediatric patients with MB were enrolled. The median follow-up time was 60 months. The 5-year OS for all patients, and patients with standard-risk and high-risk were 74.2%, 76.3% and 71.4%, respectively. Tumor tissues of 24 patients were available, of which 23 could be molecularly classified. Two, one and 20 were in the WNT, SHH and non-WNT\/non-SHH subtypes with 5-year OS of 100%, 100% and 78.9%, respectively. Using multivariate analysis, the interval of more than 8 weeks between surgery and radiotherapy was significantly correlated with a decrease in the 5-year OS.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Interval between surgery and radiotherapy within 8 weeks was associated with good therapeutic outcomes among Thai pediatric patients with MB. Simplified molecular subtyping combined with clinical characteristics is practical in risk classification of patients with MB in institutes with limited resources.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0271778","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T21:51:50Z","timestamp":1673992310000},"page":"e0271778","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Postoperative radiotherapy timing, molecular subgroups and treatment outcomes of Thai pediatric patients with medulloblastoma"],"prefix":"10.1371","volume":"18","author":[{"given":"Thitiporn","family":"Jaruthien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chonnipa","family":"Nantavithya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakun","family":"Santisukwongchote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanop","family":"Shuangshoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piti","family":"Techavichit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darintr","family":"Sosothikul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiraporn","family":"Amornfa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8714-5733","authenticated-orcid":true,"given":"Kanjana","family":"Shotelersuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"issue":"6","key":"pone.0271778.ref001","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(17)30186-9","article-title":"International incidence of childhood cancer, 2001\u201310: a population-based registry study","volume":"18","author":"E Steliarova-Foucher","year":"2017","journal-title":"Lancet Oncol"},{"key":"pone.0271778.ref002","unstructured":"American Cancer Society. Cancer Facts & Figures 2022. American Cancer Society. Atlanta, Ga. 2021. [cited 2022 October 18]. https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/cancer-facts-figures-2022.html"},{"issue":"Suppl 5","key":"pone.0271778.ref003","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012\u20132016","volume":"21","author":"QT Ostrom","year":"2019","journal-title":"Neuro Oncol"},{"issue":"10","key":"pone.0271778.ref004","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1470-2045(06)70867-1","article-title":"Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial","volume":"7","author":"A Gajjar","year":"2006","journal-title":"Lancet Oncol"},{"issue":"7","key":"pone.0271778.ref005","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1200\/JCO.20.01372","article-title":"Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)","volume":"39","author":"A Gajjar","year":"2021","journal-title":"J Clin Oncol"},{"issue":"25","key":"pone.0271778.ref006","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1200\/JCO.2006.06.4980","article-title":"Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma","volume":"24","author":"RJ Packer","year":"2006","journal-title":"J Clin Oncol"},{"issue":"26","key":"pone.0271778.ref007","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2011.39.8719","article-title":"Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial","volume":"30","author":"B Lannering","year":"2012","journal-title":"J Clin Oncol"},{"issue":"34","key":"pone.0271778.ref008","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1200\/JCO.2016.67.2428","article-title":"Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters","volume":"34","author":"AO von Bueren","year":"2016","journal-title":"J Clin Oncol"},{"issue":"3","key":"pone.0271778.ref009","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.ijrobp.2010.12.042","article-title":"Outcome and prognostic factors of radiation therapy for medulloblastoma","volume":"81","author":"S Rieken","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"pone.0271778.ref010","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/neuonc\/noy001","article-title":"Survival impact of postoperative radiotherapy timing in pediatric and adolescent medulloblastoma","volume":"20","author":"AL Chin","year":"2018","journal-title":"Neuro Oncol"},{"issue":"8","key":"pone.0271778.ref011","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"DN Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"pone.0271778.ref012","doi-asserted-by":"crossref","first-page":"607777","DOI":"10.3389\/fonc.2020.607777","article-title":"Primary Brain Tumor Research Productivity in Southeast Asia and Its Association With Socioeconomic Determinants and Burden of Disease","volume":"10","author":"MWL Mondia","year":"2020","journal-title":"Front Oncol"},{"issue":"2","key":"pone.0271778.ref013","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/JPN.JPN_111_17","article-title":"Survival and Prognostic Factors in Pediatric Patients with Medulloblastoma in Southern Thailand","volume":"13","author":"N Nalita","year":"2018","journal-title":"J Pediatr Neurosci"},{"key":"pone.0271778.ref014","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.35755\/jmedassocthai.2021.10.12989","article-title":"Clinical Characteristic and Molecular Subgroups of Thai Pediatric Medulloblastomas at Queen Sirikit National Institute of Child Health","volume":"104","author":"P Tadadontip","year":"2021","journal-title":"J Med Assoc Thai"},{"key":"pone.0271778.ref015","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1056\/NEJMoa042176","article-title":"Treatment of early childhood medulloblastoma by postoperative chemotherapy alone","volume":"352","author":"S Rutkowski","year":"2005","journal-title":"N Engl J Med"},{"key":"pone.0271778.ref016","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/neuonc\/nor025","article-title":"Treatment of young children with localized medulloblastoma by chemotherapy alone: Results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology","volume":"13","author":"AO von Bueren","year":"2011","journal-title":"Neuro-oncol"},{"issue":"7","key":"pone.0271778.ref017","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/PAI.0000000000000794","article-title":"Simplified Molecular Subtyping of Medulloblastoma for Reduced Cost and Improved Turnaround Time","volume":"28","author":"S Shuangshoti","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"3","key":"pone.0271778.ref018","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00401-011-0800-8","article-title":"Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH\/WNT molecular subgroups","volume":"121","author":"DW Ellison","year":"2011","journal-title":"Acta Neuropathol"},{"issue":"1","key":"pone.0271778.ref019","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00401-014-1276-0","article-title":"Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort","volume":"128","author":"T Pietsch","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"1","key":"pone.0271778.ref020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.18679\/CN11-6030_R.2017.003","article-title":"Factors affecting the prognosis of children with medulloblastoma: A single institution retrospective analysis of 40 cases","volume":"3","author":"JZ Yu","year":"2017","journal-title":"Transl. Neurosci. Clin"},{"issue":"4","key":"pone.0271778.ref021","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S1470-2045(15)00581-1","article-title":"Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis","volume":"17","author":"EM Thompson","year":"2016","journal-title":"Lancet Oncol"},{"issue":"4","key":"pone.0271778.ref022","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3171\/2019.5.PEDS18381","article-title":"Medulloblastoma in the age of molecular subgroups: a review","volume":"24","author":"K Juraschka","year":"2019","journal-title":"J Neurosurg Pediatr"},{"issue":"4","key":"pone.0271778.ref023","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00401-011-0922-z","article-title":"Molecular subgroups of medulloblastoma: the current consensus","volume":"123","author":"MD Taylor","year":"2012","journal-title":"Acta Neuropathol"},{"key":"pone.0271778.ref024","first-page":"755","article-title":"A 11-year experience of radiation therapy for medulloblastoma at King Chulalongkorn Memorial Hospital","volume":"45","author":"K Shotelersuk","year":"2001","journal-title":"Chula Med J"},{"issue":"24","key":"pone.0271778.ref025","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1200\/JCO.20.02730","article-title":"Children\u2019s Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma","volume":"39","author":"JM Michalski","year":"2021","journal-title":"J Clin Oncol"},{"issue":"22","key":"pone.0271778.ref026","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.4161\/cc.5.22.3446","article-title":"Wnt\/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis","volume":"5","author":"SC Clifford","year":"2006","journal-title":"Cell Cycle"},{"issue":"8","key":"pone.0271778.ref027","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/sj.bjc.6604979","article-title":"An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET)","volume":"100","author":"HA Rogers","year":"2009","journal-title":"Br J Cancer"},{"issue":"4","key":"pone.0271778.ref028","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/PAS.0000000000001640","article-title":"Diagnostic Accuracy of a Reduced Immunohistochemical Panel in Medulloblastoma Molecular Subtyping, Correlated to DNA-methylation Analysis","volume":"45","author":"A Tauzi\u00e8de-Espariat","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"pone.0271778.ref029","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jamaoncol.2016.2547","article-title":"Postoperative Radiotherapy Patterns of Care and Survival Implications for Medulloblastoma in Young Children","volume":"2","author":"BH Kann","year":"2016","journal-title":"JAMA Oncol"},{"issue":"3","key":"pone.0271778.ref030","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/mpo.2950250303","article-title":"Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II","volume":"25","author":"CC Bailey","year":"1995","journal-title":"Med Pediatr Oncol"},{"issue":"2","key":"pone.0271778.ref031","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0360-3016(99)00369-7","article-title":"Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT \u201991","volume":"46","author":"RD Kortmann","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0271778","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T21:52:21Z","timestamp":1673992341000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0271778"}},"subtitle":[],"editor":[{"given":"Yasunori","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0271778","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,17]]}}}